ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Generic Drug User Fees, Funding for FDA, Funding for the Office of Generic Drugs, FY12 Presidential Budget Request, FY11 and FY12 Budget
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN COSTER New | — |
| CHRISTOPHER DAVIS New | — |
| MARK D HENDRICKSON New | — |
| JASON R MONEY | — |
Trade (domestic/foreign) TRD
Free Trade Agrements - Trans Pacific Partnership, Korean Free Trade Agreement, Anti-Counterfeiting Trade Agreement (ACTA), Generic medicines
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN COSTER New | — |
| CHRISTOPHER DAVIS New | — |
| MARK D HENDRICKSON New | — |
| JASON R MONEY | — |
Copyright/Patent/Trademark CPT
Patent Reform, Patent Settlements/Reverse Payments/Exclusionary Payments, Patent term extensions, Generic drugs H.R.5 - Help Efficient, Accessible, Low-cost, Timely Healthcare (Health) Act of 2011 S.23 and H.R.1249 - America Invents Act, Sections 10 and 11 (Supplemental Examination) S.27 - Preserve Access to Affordable Generics Act, all provisions S.373 - Fair Prescription Drug Competition Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN COSTER New | — |
| CHRISTOPHER DAVIS New | — |
| MARK D HENDRICKSON New | — |
| JASON R MONEY | — |
Medicare/Medicaid MMM
FY11 and FY12 Budget, Implementation of Health Care Reform, Medicaid Rebates, prescription drug reimbursement, Average Manufacture Price (AMP)/AMP Publication, generic drugs S.44 - Medicare Prescription Drug Negotiation Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN COSTER New | — |
| CHRISTOPHER DAVIS New | — |
| MARK D HENDRICKSON New | — |
| JASON R MONEY | — |
Pharmacy PHA
FY 2011 and FY2012 Budget, Implementation of Health Care Reform, Implementation of Generic Biologics, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Prescription Drug Shortages, Authorized Generics, Prescription Drug Importation/Re-Importation, and generic drugs S.44 - Medicare Prescription Drug Negotiation Act S.296 - Preserving Access to Life-Saving Medications Act S.373 - Fair Prescripton Drug Competition Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN COSTER New | — |
| CHRISTOPHER DAVIS New | — |
| MARK D HENDRICKSON New | — |
| JASON R MONEY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.